Responses
Immunotherapy biomarkers
Original research
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.